Moreover, immunostaining demonstrated that the expression of ST6GAL2 was up-regulated in the FTC tissues with high expression of HCP5 as well as in xenograft tumour tissues in the FTC133/HCP5 group. Here, ST6GAL2 is linked to neoplasm.